peginterferon alfa-2a

<http://www.wikidata.org/entity/Q420056>

pharmaceutical drug
rdfs:label
"peginterferon alfa-2a"@en
skos:altLabel
"Pegasys"@en
"pegylated ifn-alpha-2a"@en
"Ro-258310000"@en
"Roferon-A"@en
schema:description
"pharmaceutical drug"@en
schema:dateModified "2026-07-04T10:47:09+00:00"^^xsd:dateTime
schema:version 2513769654
wikibase:identifiers 21
wikibase:sitelinks 20
wikibase:statements 40
p:P10245 wd:statement/Q420056-d8eae6f1-4c04-13b4-1429-ec92cb7714ea
p:P10283 wd:statement/Q420056-FEF8B159-2C68-430C-A56F-6BFAA292A447
p:P11143 wd:statement/Q420056-54B79ACD-3DBE-4B38-BFEF-A38EEE6EBF74
p:P117 wd:statement/Q420056-E207A64B-7D06-425E-A538-E854E85C6C4B
p:P1552 wd:statement/Q420056-35244F08-99CB-495F-B317-B9CFC7F02377
p:P2062 wd:statement/Q420056-6F260AF0-FCCD-465E-8415-C956113B3CD8
p:P2115 wd:statement/Q420056-595EC710-3105-42DB-8793-A62856465791
wd:statement/Q420056-B9E2811D-0D0E-418F-AA26-90FF57BB3EAC
p:P2175 wd:statement/Q420056-304BF580-37E2-4AF4-9D23-A71A3A3AE315
wd:statement/Q420056-4B93FB2F-08D9-4B71-A3D5-BB82C940F922
wd:statement/Q420056-690F97F8-CF5A-47F4-8E52-8F4CF3DD9396
wd:statement/Q420056-6ED80EB7-9E7B-4AC2-9C83-83652ED52A0C
wd:statement/Q420056-9580EACE-99A6-4653-8DEA-E996AC6A6AC1
wd:statement/Q420056-9D27F907-684D-46E2-A0E5-E920B003BF10
wd:statement/Q420056-B71F2F2A-FBFD-49F3-9145-3BA476F16017
wd:statement/Q420056-E5AFB953-80C2-4116-94DB-FD82D74D5487
p:P231 wd:statement/Q420056-1046078A-034F-4CDE-ACBF-42D906B1BFB4
p:P267 wd:statement/Q420056-97C748C7-E42D-43D2-96AC-F9C03F074F40
p:P279 wd:statement/Q420056-5527E3BB-CEA3-4A0B-8D17-F84CA76CD2C5
p:P2868 wd:statement/Q420056-5CFF894E-7414-4351-86F0-FB9F10F722A2
wd:statement/Q420056-A317E315-00BA-4F64-A59F-081A3A436C75
wd:statement/Q420056-E7BF6820-BB90-41AD-A197-627C3EFB9B48
p:P2892 wd:statement/Q420056-AE0B8482-9C51-4F41-B5A3-050DCD7B8603
p:P31 wd:statement/Q420056-9D4ADBEB-BE43-4515-AE91-6F2DAF34601E
p:P3345 wd:statement/Q420056-E10B914F-162C-4E7F-A2F0-F5A9F7690CE3
p:P3493 wd:statement/Q420056-E6C40054-06F7-4718-946C-1491B440114C
p:P366 wd:statement/Q420056-477F120A-F02B-482A-BC88-25B11C95D6D8
p:P3780 wd:statement/Q420056-5A7C0DFF-6A21-4686-9A5D-722AEA5C8564
p:P4235 wd:statement/Q420056-638A6AC3-9F79-4E93-B194-3F18E1D71EEC
p:P4250 wd:statement/Q420056-0992BDDF-B6CC-4E7F-822B-D94E3516BDA5
p:P486 wd:statement/Q420056-9F06F1D1-51E2-4697-942D-9BF2337BF3F0
p:P592 wd:statement/Q420056-51A4BCEF-E3F5-452F-BDF4-C0F2C41E29C0
p:P595 wd:statement/Q420056-8fcdc75f-4b40-dc9f-dda1-ee2a98a30eb4
p:P6366 wd:statement/Q420056-538C1AB2-3B64-41CB-AF24-262F1B5D7F06
wd:statement/Q420056-53EF2C67-2236-4CEF-8715-FEA36965B6C7
p:P646 wd:statement/Q420056-EF2F952C-3E67-4647-BD2B-D942B53F4542
p:P652 wd:statement/Q420056-8663F7CC-EA8F-47AE-B151-8AD18BB74C75
p:P665 wd:statement/Q420056-5CDB9257-F53A-45F1-B712-8A2ADD774994
p:P691 wd:statement/Q420056-3766BB45-D804-4872-A8F7-7FC6F1261FD6
p:P715 wd:statement/Q420056-DD184418-D2ED-41DE-B711-DC003C07C1B0
p:direct-normalized/P2115 <http://purl.bioontology.org/ontology/NDFRT/N0000148781>
<http://purl.bioontology.org/ontology/NDFRT/N0000178330>
p:direct-normalized/P486 <http://id.nlm.nih.gov/mesh/C100416>
p:direct-normalized/P592 <http://rdf.ebi.ac.uk/resource/chembl/molecule/CHEMBL1201560>
p:direct-normalized/P6366 <https://makg.org/entity/2776235749>
<https://makg.org/entity/2908519312>
p:direct-normalized/P665 <http://www.kegg.jp/entry/D02748>
wdt:P10245 "a605029"
wdt:P10283 "C2776235749"
wdt:P11143 "Peginterferon alfa-2a"
wdt:P117 <http://commons.wikimedia.org/wiki/Special:FilePath/Peginterferon%20alfa-2a.png>
wdt:P1552 medicamento biolóxico
wdt:P2062 "8140"
wdt:P2115 "N0000148781"
"N0000178330"
wdt:P2175 Полицитемија Рубра Вера
原發性血小板增多症
Mielofibrosi
hepatitis B crónica
Гепатит B
hepatitis
肝硬化
hepatitis C
wdt:P231 "198153-51-4"
wdt:P267 "L03AB11"
wdt:P279 pegilirana spojina
wdt:P2868 protivirusna učinkovina
factor inmunolóxico
medicamente esențiale
wdt:P2892 "C0391001"
wdt:P31 тып хімічнага аб’екта
wdt:P3345 "120608"
wdt:P3493 casetă de avertizare
wdt:P366 dược phẩm
wdt:P3780 Pegasys
wdt:P4235 "peginterferon-alfa-2a"
wdt:P4250 26.0^^xsd:decimal
wdt:P486 "C100416"
wdt:P592 "CHEMBL1201560"
wdt:P595 "4960"
wdt:P6366 "2776235749"
"2908519312"
wdt:P646 "/m/07p3pf"
wdt:P652 "Q46947FE7K"
wdt:P665 "D02748"
wdt:P691 "ph685416"
wdt:P715 "DB00008"

Inverse relations

[ .. ] → wdt:P4844 → peginterferon alfa-2a

48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C Patients A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072 A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism A Study in Healthy Volunteers and Patients With Chronic Hepatitis B (2016-11-30) A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program. A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B. A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B. A Study of Pegasys (Peginterferon Alfa-2a) Versus Untreated Control in Children With HBeAg Positive Chronic Hepatitis B A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV) A Study of RO5024048 in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C, Genotype 1 or 4 A Study of Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3) A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir A Study of the Pharmacokinetics And Pharmacodynamics of Intravenously Administered Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C And Previous Non-Response to Pegylated Interferon And Ribavirin Combination Therapy A Study of the Safety of Individualized Combination Therapy With Copegus (Ribavirin) and Pegasys (Peginterferon Alfa-2a) in Patients With Chronic Hepatitis C (MASTER) ... show all 93

[ .. ] → wdt:P921 → peginterferon alfa-2a

Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy (2005-02-28) Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral Load Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms Efficacy of Pegylated Interferon on Liver Fibrosis in Co-infected Patient With HIV and Hepatitis C Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients Optimization of Antiviral Therapy of Chronic HBV Infection PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR) Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in Hepatitis C Virus (HCV)-Genotype-1-Infection (PRAMA) Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients Response to Pegylated Interferon and Ribavirin in Chinese Patients With Chronic Hepatitis C Genotypes 1 Versus 2/3 Versus 6 Sofosbuvir (GS-7977) in Combination With PEG and Ribavirin for 12 Weeks in Treatment Experienced Subjects With Chronic HCV Infection Genotype 2 or 3

[ .. ] → schema:about → peginterferon alfa-2a

Alfapeginterferona 2aschema:Article Category:Interferon-alpha 2aschema:Article Pegilirani interferon alfa-2aschema:Article Pegilirani interferon alfa-2aschema:Article Pegilirani interferon alfa-2aschema:Article Peginterferon alfa-2aschema:Article Peginterferon alfa-2aschema:Article Peginterferon alfa-2aschema:Article Peginterferon alfa-2aschema:Article Peginterferon alfa-2aschema:Article Peginterferon alfa-2aschema:Article Peginterferon αschema:Article Peginterferón alfa-2aschema:Article Peginterféron alfa-2aschema:Article Пегилированный интерферон альфа-2аschema:Article Пегільований інтерферон альфа-2аschema:Article بيغنتيرفيرون – ألفا – 2أschema:Article ପେଜିଣ୍ଟରଫେରନ ଆଲଫା-୨ଏschema:Article 聚乙二醇化干擾素α-2aschema:Article 페그인터페론 알파-2aschema:Article

[ .. ] → p:statement/P4844 → peginterferon alfa-2a

<http://www.wikidata.org/entity/statement/Q63339365-54775359-AE09-4864-B26B-4E3AAE0B4B82>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q63337254-B5401884-76AE-436C-80EC-426F63F5704A>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q63338615-43717949-7262-4286-B0E2-FC4616DD3AAF>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q61918517-D846D1C3-1106-4675-BEA8-459438228210>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q61917593-79C58882-6925-49D1-921E-3B7E9A98D19E>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q86158150-8937D294-50DE-4941-947D-CE0F5D40D7AE>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q61920908-03E3F9D2-A1B6-490B-807D-152489A6FF54>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q63339075-05423C1B-4808-43A7-B2C6-954E5E06853D>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q61921872-4279EFDB-9B31-436D-9D28-EBB5BA7CAB56>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q61917571-DBDE092B-D3D0-4BB7-897C-C797487A7AE7>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q61921939-6EF60F27-60D9-4BC2-8059-C9DC465DB3E8>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q61918300-2BC747FA-408A-488C-B1A4-A19455C442F8>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q113914448-150585A5-88F9-426D-A6EE-C0B1A9945758>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q63338993-95023614-360E-4845-90E7-18ECB20C7570>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q61914804-0283E7CF-F56C-4B37-B2E2-CB84F6905C66>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q87078585-AD9BCBF8-3E9F-4E37-A2DA-515D18CADC49>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q92391977-66D46488-2959-4509-9EF3-3A436CEABABA>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q61915185-11095D70-0D0A-4216-B4CB-FE0938D04045>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q63811635-62CA2D80-6FCA-4528-B9D1-C0D05B1A4AA2>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q113913031-567CDA97-3D65-4C2A-8D7E-61720F061F20>wikibase:BestRank ... show all 93

[ .. ] → p:statement/P2176 → peginterferon alfa-2a

<http://www.wikidata.org/entity/statement/Q55779876-EF5F7CA5-2465-46AE-82EE-F198CE5E3946>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q1368780-31AB7656-C5FC-4E58-AC63-1B443671464E>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q6853-03C44313-00E3-46D2-910C-7B1D311A022E>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q154869-5C350DB7-51DE-4F13-B243-D9A7928B58DD>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q147778-E95CF0A3-C3A8-4870-BCD0-16C16E7E2F9C>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q948318-F64D446B-1E81-4739-8E2B-61FB3E37916C>wikibase:BestRank

[ .. ] → wdt:P2176 → peginterferon alfa-2a

B hepatitis myelofibrose цироза јетре التهاب الكبد ب المزمن التهاب كبدي كثرة الحمر الحقيقية ഹെപ്പറ്റൈറ്റിസ്-സി 納拉甘西特灣

[ .. ] → wdt:P527 → peginterferon alfa-2a

قائمة الأدوية الأساسية النموذجية لمنظمة الصحة العالمية

[ .. ] → wdt:P1056 → peginterferon alfa-2a

Pharma&

[ .. ] → p:statement/P921 → peginterferon alfa-2a

<http://www.wikidata.org/entity/statement/Q64626440-968F13C1-C0B7-4BF4-9AA9-AF0C8E1F7D4F>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q64677189-E5D1A443-6D0B-4A2C-81FD-2740D1358634>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q66033699-B5E171BC-FC62-46C7-8934-AEABBCFF11A4>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q65380817-CDD4532B-4483-4A19-A7AC-2F05E3213561>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q64656610-58E4C3FE-9FEA-47F8-9BF7-753D3A2076AE>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q63842289-1C5B8090-3E7F-4090-82F8-94D137D64EBF>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q66059045-292AB40B-82CF-4502-808D-D3C65C55D44C>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q65469683-BC6B1511-7AC3-482F-A595-C76E12B2108D>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q64663008-A7B519C3-3E94-4A84-9C52-BBA7D2A6F310>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q63839845-6BE520C7-4581-4AD4-AA2D-A3F8D2750852>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q86248837-B95D551E-8C1E-4B52-B27A-204C25A636FA>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q66032075-3FF42F2D-6204-4D86-BBC6-38A071F1E9FA>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q65535867-3903147B-C6FA-4993-856C-AF4614C9CA49>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q63836959-550883AD-1FD1-404E-BEB5-14E6F7E0AEFD>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q64665230-B1016A03-2686-4D7C-BCE9-21B104834D99>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q64648087-F48DB0A9-302B-4652-BBFC-3971887E0C0B>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q64676731-A2F6AC54-DD93-4BA3-8610-318C31066318>wikibase:BestRank <http://www.wikidata.org/entity/statement/Q64719818-8F8B9D29-7F20-4724-AA31-83A79876DBE7>wikibase:BestRank

[ .. ] → wdt:P3354 → peginterferon alfa-2a

CALR EXON 9 FRAMESHIFT

[ .. ] → wdt:P3781 → peginterferon alfa-2a

Pegasys
Download as:
RDF/XML JSON-LD Turtle
data from SPARQL endpoint: https://query.wikidata.org/sparql